|* Risks and benefits of restarting HIV prevention activities in the midst of on-going COVID-19 epidemics||John Stover (Avenir Health)|
|* Informing VMMC provision in districts within countries in sub-Saharan Africa||Loveleen Bansi-Matharu (UCL)|
|* Informing cost effective interventions to maximise continued engagement on ART in people with HIV (formerly: Effectiveness, cost-effectiveness, and respiratory infection control benefits of expanding community delivery and task-shifting for HIV/AIDS services)||Anna Bershteyn (NYU), Brooke Nichols (H2RO and BU)|
|* Modelling evidence about evolving age/sex patterns of HIV incidence to guide UNAIDS HIV estimates tools in sub-Saharan Africa||Jeff Eaton (Imperial College London), Leigh Johnson (UCT)|
|Modelling the effects of structural interventions and social enablers on HIV incidence and mortality in sub-Saharan African countries||Leigh Johnson (UCT)|
|Modelling to Inform HIV Programmes in sub-Saharan Africa (MIHPSA Collaboration)||Edward Kataika (East, Central and Southern Africa Health Community), Paul Revill (University of York), Andrew Phillips (UCL)|
|MIHPSA Malawi sub-project||Carel Pretorius (Avenir Health), Sherrie Kelly (Burnet Institute), Rose Nyirenda (MOH Malawi)|
|MIHPSA South Africa sub-project||Leigh Johnson (UCT), Edinah Mudimu (University of South Africa), Thato Chidarikire (NDoH South Africa)|
|MIHPSA Zimbabwe sub-project||Valentina Cambiano (UCL), Isaac Taramusi (NAC Zimbabwe)|
|The incremental benefit of Advanced HIV Disease (AHD) focussed interventions on AIDS mortality||Amir Shroufi, Gilles van Cutsem (MSF), Ken Freedberg (MGH, Harvard), Emily Hyle (MGH, Harvard)|
|Assessing the impact and utility of long acting PrEP to help control HIV epidemics in various risk population and settings||Marie-Claude Boily (Imperial College London), Dobromir Dimitrov (Fred Hutchinson Cancer Research Center)|
|* Oral HIV self tests expand PrEP access in sub-Saharan Africa||Katy Godfrey (Office of the Global AIDS Coordinator, Dept of State USA), Andrew Phillips (UCL)|
|* Cost-effectiveness of easy-access risk-informed oral pre-exposure prophylaxis (PrEP) in HIV epidemics in sub-Saharan Africa||Andrew Phillips (UCL)|
*These projects are closed to new collaborators.
Please get in touch with email@example.com if you would like more information or are interested in contributing to a project.